Log In
Print
BCIQ
Print
Print this Print this
 

cenderitide (formerly CD-NP)

  Manage Alerts
Collapse Summary General Information
Company Capricor Therapeutics Inc.
DescriptionSelective natriuretic peptide receptor A (NPR1; NPRA) and natriuretic peptide receptor B (NPR2; NPRB) agonist
Molecular Target Natriuretic peptide receptor A (NPR1) (NPRA) ; Natriuretic peptide receptor B (NPR2) (NPRB)
Mechanism of ActionNatriuretic peptide receptor B (NPRB) agonist; Natriuretic peptide receptor A (NPRA) agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat acute decompensated heart failure (ADHF); Treat acute heart failure (AHF); Treat outpatient acute decompensated heart failure (ADHF); Treat stable chronic heart failure
Regulatory Designation U.S. - Fast Track (Treat acute decompensated heart failure (ADHF))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today